ADC Therapeutics SA banner

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.13 USD -3.28% Market Closed
Market Cap: $511.6m

Cash Flow Statement

Cash Flow Statement
ADC Therapeutics SA

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2019 Dec-2019 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(142)
(116)
(237)
(226)
(246)
(298)
(200)
(252)
(230)
(195)
(187)
(166)
(156)
(199)
(181)
(179)
(240)
(227)
(217)
(213)
(158)
(150)
(170)
(167)
Depreciation & Amortization
1
2
2
2
2
3
2
3
3
3
3
3
2
2
3
3
1
1
2
2
1
1
0
(0)
Change in Deffered Taxes
0
0
0
0
0
0
0
0
(26)
(30)
(34)
(34)
(1)
2
(1)
(2)
37
38
45
46
0
0
0
0
Stock-Based Compensation
1
1
12
23
38
52
59
62
60
60
55
55
49
44
31
19
13
6
6
7
7
9
9
8
Other Non-Cash Items
(1)
0
92
71
64
59
(19)
30
46
42
41
76
83
110
114
65
37
31
22
17
27
26
36
37
Cash Taxes Paid
0
0
0
0
0
(0)
0
1
1
1
9
11
13
14
2
(3)
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
2
2
3
4
4
5
7
11
15
21
27
27
28
0
15
13
12
16
15
15
15
Change in Working Capital
(6)
(7)
4
2
12
12
7
(5)
(26)
(32)
(29)
(25)
(66)
(34)
(36)
(25)
46
9
4
13
5
(14)
7
(1)
Cash from Operating Activities
(148)
N/A
(122)
+18%
(139)
-14%
(151)
-9%
(169)
-12%
(224)
-33%
(209)
+7%
(223)
-7%
(233)
-4%
(212)
+9%
(207)
+2%
(146)
+29%
(137)
+7%
(118)
+14%
(102)
+14%
(138)
-36%
(119)
+14%
(148)
-25%
(144)
+3%
(135)
+6%
(124)
+8%
(136)
-10%
(127)
+6%
(132)
-4%
Investing Cash Flow
Capital Expenditures
(4)
(2)
(1)
(2)
(3)
(3)
(6)
(7)
(6)
(7)
(5)
(3)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(1)
(1)
(1)
(1)
(0)
Other Items
0
(0)
0
0
(0)
(0)
0
0
(0)
(1)
(1)
(1)
(0)
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(4)
N/A
(2)
+43%
(1)
+57%
(2)
-141%
(3)
-21%
(3)
-23%
(6)
-64%
(7)
-16%
(7)
-1%
(7)
-12%
(5)
+29%
(3)
+39%
(3)
+22%
(2)
+17%
(2)
-15%
(3)
-17%
(3)
-14%
(3)
+15%
(2)
+36%
(1)
+25%
(1)
+34%
(1)
+31%
(1)
+5%
(0)
+38%
Financing Cash Flow
Net Issuance of Common Stock
101
102
244
436
433
433
189
(2)
1
1
1
6
6
0
0
0
1
1
100
99
98
98
93
94
Net Issuance of Debt
(1)
(1)
62
62
62
61
49
268
267
267
217
(6)
(7)
(6)
69
70
73
0
(1)
1
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
0
(1)
(1)
Cash from Financing Activities
101
N/A
101
0%
306
+205%
498
+63%
495
-1%
495
0%
238
-52%
266
+12%
267
+1%
267
+0%
218
-19%
1
-100%
(1)
N/A
(1)
+10%
74
N/A
70
-6%
74
+6%
74
+1%
98
+32%
100
+1%
97
-3%
97
0%
92
-5%
93
+1%
Change in Cash
Effect of Foreign Exchange Rates
(0)
0
(0)
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
(0)
0
0
(0)
Net Change in Cash
(51)
N/A
(23)
+55%
166
N/A
345
+107%
324
-6%
268
-17%
23
-91%
36
+54%
27
-24%
48
+75%
5
-90%
(149)
N/A
(140)
+6%
(120)
+14%
(29)
+76%
(70)
-141%
(48)
+32%
(76)
-59%
(47)
+38%
(36)
+24%
(28)
+23%
(40)
-43%
(36)
+10%
(40)
-11%
Free Cash Flow
Free Cash Flow
(152)
N/A
(124)
+18%
(139)
-13%
(153)
-10%
(172)
-12%
(227)
-33%
(215)
+5%
(230)
-7%
(240)
-4%
(219)
+9%
(212)
+3%
(149)
+30%
(139)
+7%
(120)
+14%
(104)
+13%
(141)
-35%
(122)
+13%
(151)
-24%
(146)
+3%
(136)
+6%
(125)
+8%
(137)
-10%
(128)
+6%
(132)
-3%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett